Christopher S. Henney, Director at Anthera Pharmaceuticals Inc (ANTH), bought 100,000 shares at $0.75 ($75K) on 2012-06-29, disclosed to the SEC on 2012-07-02.
Open-market purchase of $75k ANTH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| PRTA | SELL | 2021-06-29 | $1.1M | — | Filing → |
| PRTA | SELL | 2017-09-29 | $63K | — | Filing → |
| PRTA | SELL | 2017-07-19 | $331K | — | Filing → |